Judith Hills PhD, is currently with Ipsen Biopharm Ltd, where she leads the Corporate Business Development team as Senior Vice President. Judith joined Ipsen Biopharm in 2012 bringing her skills and experience to align deal activity to the company strategy, and since then has played an integral part in the execution of many transformational deals. Prior to her current role, Judith worked for many years in senior level VP roles leading BD teams within GlaxoSmithKline and Bristol Myers Squibb.
Judith started her career in industry after completing her PhD at University College London and postdoctoral research positions also within the University of London, UK.
As a well-known BD professional, Judith has a deep understanding of the basic science, disease landscape, therapeutic intervention strategies, and the current regulatory and competitor environment.